Northwest & Ethical Investments L.P. lifted its stake in Relx Plc (NYSE:RELX – Free Report) by 5.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 210,600 shares of the technology company’s stock after acquiring an additional 11,139 shares during the period. Northwest & Ethical Investments L.P.’s holdings in Relx were worth $9,565,000 at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. CENTRAL TRUST Co increased its holdings in Relx by 1,290.2% during the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock worth $26,000 after acquiring an additional 529 shares during the period. Versant Capital Management Inc purchased a new position in shares of Relx during the 4th quarter valued at $31,000. Sierra Ocean LLC bought a new position in shares of Relx in the fourth quarter worth $43,000. Private Trust Co. NA raised its position in shares of Relx by 119.9% in the third quarter. Private Trust Co. NA now owns 1,038 shares of the technology company’s stock worth $49,000 after buying an additional 566 shares in the last quarter. Finally, Whipplewood Advisors LLC bought a new stake in Relx during the fourth quarter valued at $74,000. 15.02% of the stock is currently owned by hedge funds and other institutional investors.
Relx Trading Up 1.2 %
NYSE RELX opened at $49.94 on Friday. The stock’s 50-day simple moving average is $49.11 and its two-hundred day simple moving average is $47.67. Relx Plc has a twelve month low of $40.25 and a twelve month high of $51.99. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. The company has a market capitalization of $92.70 billion, a price-to-earnings ratio of 26.85, a PEG ratio of 2.73 and a beta of 0.90.
Relx Increases Dividend
Analyst Upgrades and Downgrades
RELX has been the topic of a number of research analyst reports. StockNews.com lowered Relx from a “buy” rating to a “hold” rating in a research note on Tuesday, March 4th. Redburn Atlantic started coverage on shares of Relx in a research note on Wednesday, January 8th. They issued a “buy” rating on the stock. Finally, Barclays upgraded shares of Relx from an “equal weight” rating to an “overweight” rating in a research report on Friday, March 14th.
View Our Latest Analysis on Relx
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Articles
- Five stocks we like better than Relx
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Investing In Automotive Stocks
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.